Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis
Obstetrics and Gynecology International · 03.09.2020 · 2020 · 1-12
DOI: 10.1155/2020/2374716 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Obstetrics and Gynecology International, erschienen am 03.09.2020. Verfasst von Kristin S Weeks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, College of Public Health, University of Iowa, Iowa City 52242, IA, USA. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, University of Iowa, National Institutes of Health.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Venous thromboembolisms (VTEs) have been a leading secondary cause of death among ovarian cancer patients, prompting multiple studies of risk factors. The objective of this meta-analysis is to quantify the associations between VTE and the most commonly reported risk factors among ovarian cancer patients. PubMed, Embase, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) were used to identify observational studies. Two reviewers independently abstracted data and assessed quality via the Newcastle–Ottawa tool. A random effects model was used to calculate the pooled odds ratios for VTE with each of the following exposures: advanced cancer stage, clear cell histology, serous histology, ascites at diagnosis, and complete cytoreduction. The I 2 and Q tests were used to evaluate heterogeneity. Twenty cohort studies with 6,324 total ovarian cancer patients, 769 of whom experienced a VTE, were included. The odds of VTE in ovarian cancer patients were higher among patients with cancer stage III/IV (versus cancer stage I/II, pooled odds ratio (OR) 2.73; 95% CI 1.84–4.06; I 2 = 64%), clear cell (versus nonclear cell) histology (OR 2.11; 95% CI 1.55–2.89; I 2 = 6%), and ascites (versus no ascites) at diagnosis (OR 2.12; 95% CI 1.51–2.96; I 2 = 32%). Serous (versus nonserous) histology (OR 1.26; 95% CI 0.91–1.75; I 2 = 42%) and complete (versus incomplete) cytoreduction (OR 1.05; 95% CI 0.27–4.11; I 2 = 88%) were not associated with VTE. This meta-analysis quantifies the significantly elevated odds of VTE in ovarian cancer patients with advanced stage at diagnosis, clear cell histology, and ascites at diagnosis. Further studies are needed to account for confounders and inform clinical decision-making tools.
Autor:innen und Institutionen
- Department of Epidemiology, College of Public Health, University of Iowa, Iowa City 52242, IA, USA.
- Carver College of Medicine, University of Iowa, Iowa City 52242, IA, USA.
- Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City 52242, IA, USA.
- Center for Access and Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City 52242, IA, USA.
ORCID-Profile: Kristin S Weeks
Förderung
- NIGMS NIH HHS
- University of Iowa
- National Institutes of Health
Zitieren
APA
Weeks, K. S., Herbach, E., McDonald, M., Charlton, M., & Schweizer, M. L. (2020). Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis. Obstetrics and Gynecology International, 2020, 1-12. https://doi.org/10.1155/2020/2374716
Vancouver
Weeks KS, Herbach E, McDonald M, Charlton M, Schweizer ML. Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis. Obstetrics and Gynecology International. 2020;2020:1-12. doi:10.1155/2020/2374716
BibTeX
@article{Weeks2020,
author = {Weeks, Kristin S and Herbach, Emma and McDonald, Megan and Charlton, Mary and Schweizer, Marin L},
title = {Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis},
journal = {Obstetrics and Gynecology International},
year = {2020},
volume = {2020},
pages = {1--12},
doi = {10.1155/2020/2374716}
}
EUVIMED